secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outlook Therapeutics, Inc. (OTLK)
CIK:        0001649989
Form:       8-K
Filed at:   2026-06-26T21:30:25+00:00
Accession:  0001104659-26-078337
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Outlook Therapeutics regains Nasdaq minimum bid price compliance, delisting risk removed
--------------------------------------------------------------------------------

- Received Nasdaq letter on June 26, 2026 confirming compliance with bid price rule 5550(a)(2).
- Closing bid price was $1.00 or greater for ten consecutive business days from June 11-25, 2026.
- Prior delisting notice from February 18, 2026 for failing minimum bid price is now closed.
- Common stock (OTLK) remains listed on Nasdaq Capital Market without further action needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649989/000110465926078337/0001104659-26-078337-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649989/000110465926078337/tm2619105d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-078337

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer